PAION’s mission is to be a leading specialty pharmaceutical company in the fields of anesthesia and critical care by bringing novel products to market to benefit patients, doctors and other stakeholders in healthcare.
Teleconference & webcast
23. August 2021
PAION ASSIGNS CHINESE REMIMAZOLAM PATENTS AND SELLS RELATED FUTURE...
PAION AG / Key word(s): Contract PAION ASSIGNS CHINESE...
PAION SUBMITS EXTENSION APPLICATION OF MARKETING AUTHORIZATION FOR REMIMAZOLAM...
DGAP-News: PAION AG / Key word(s): Regulatory Admission...
PAION AG PUBLISHES GROUP QUARTERLY STATEMENT FOR THE FIRST NINE MONTHS OF...
DGAP-News: PAION AG / Key word(s): Quarterly / Interim Statement...
I consent to the display of external content. This enables personal data to be transmitted to third-party platforms. Read more about our